ARVN FY2025 SEC EDGAR DEF 14A #127 of 168 in industry

Arvinas, Inc. CEO pay ratio

The CEO earned $328K in FY2025 against median worker pay of $327,724 · Chemicals & Pharmaceuticals.

Chemicals & Pharmaceuticals peers All rankings
State
DE
Filing date
2026-04-29
Industry
Chemicals & Pharmaceuticals
Industry rank
#127/168

Data updated August 2026

Subscribe to Arvinas, Inc. CEO pay filing updates (RSS)

CEO-to-worker pay ratio
20:1
Below Average (Scale: 0–1000:1)
CEO pay
$328K
Median worker
$327,724

Answer first

Arvinas, Inc.'s FY2025 CEO total of $328K ranks #1303 of 1,423 complete filings; its 20:1 pay ratio ranks #1215. Dollar rank is not ratio rank.

According to the same FY2025 complete-filing cohort used on the rankings boards (CEO total, median worker, and ratio all present). Median worker pay is $327,724. Industry placement uses the FY2025 SIC-28 peer cohort (# 127 of 168, 25th percentile - below the industry median pay ratio). Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Chemicals & Pharmaceuticals companies.

Dollar rank
#1303
$328K of 1,423 FY2025
Ratio rank
#1215
20:1 of 1,423
Industry pct
25th
below the industry median pay ratio

How Arvinas, Inc. ranks nationally

Arvinas, Inc. CEO pay vs. every FY2025 complete filing

Total CEO compensation, the full national distribution, this company marked

$327,724 8th percentile higher than 8% of 1,423 companies

$0–$2,500,000: 304 companies (21%). This entry sits in this band. $2,500,000–$5,000,000: 182 companies (13%). Above this entry. $5,000,000–$7,500,000: 208 companies (15%). Above this entry. $7,500,000–$10,000,000: 192 companies (13%). Above this entry. $10,000,000–$12,500,000: 139 companies (10%). Above this entry. $12,500,000–$15,000,000: 91 companies (6%). Above this entry. $15,000,000–$17,500,000: 88 companies (6%). Above this entry. $17,500,000–$20,000,000: 54 companies (4%). Above this entry. $20,000,000–$22,500,000: 24 companies (2%). Above this entry. $22,500,000–$25,000,000: 34 companies (2%). Above this entry. $25,000,000–$27,500,000: 24 companies (2%). Above this entry. $27,500,000–$30,000,000: 16 companies (1%). Above this entry. $30,000,000–$32,500,000: 10 companies (1%). Above this entry. $32,500,000–$35,000,000: 7 companies (0%). Above this entry. $35,000,000–$37,500,000: 9 companies (1%). Above this entry. $37,500,000–$40,000,000: 6 companies (0%). Above this entry. $40,000,000–$42,500,000: 1 companies (0%). Above this entry. $42,500,000–$45,000,000: 1 companies (0%). Above this entry. $45,000,000–$47,500,000: 6 companies (0%). Above this entry. $47,500,000–$50,000,000: 27 companies (2%). Above this entry. This company $0 $50M+ every complete-filing company, bucketed by value

Each bar is a $2500K-wide band; taller bars hold more companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source SEC DEF 14A Section 953(b) disclosures, PlainCEOPay extract · FY2025

Arvinas, Inc. vs. Chemicals & Pharmaceuticals peers

CEO total pay ($328K) against pay ratio (20:1) for Arvinas, Inc. (marked) and its 5 closest same-industry peers, against the Chemicals & Pharmaceuticals industry median on both axes.

Pay + gap both highContained pay, wide gapHigh pay, contained gapBelow peer norms on both02253862.04507724.16761586.19015448.217.9:124.2:130.5:136.8:143.1:1CEO total payPay ratio (CEO : median worker)Arvinas, Inc., CEO total pay: 327724 · Pay ratio (CEO : median worker): 20:1Arvinas, Inc.Syndax Pharmaceuticals Inc, CEO total pay: 7281788 · Pay ratio (CEO : median worker): 19:1Syndax Pharmaceuticals IncAkebia Therapeutics, Inc., CEO total pay: 5652339 · Pay ratio (CEO : median worker): 21:1Akebia Therapeutics, Inc.uniQure N.V., CEO total pay: 3287434 · Pay ratio (CEO : median worker): 19:1uniQure N.V.Kymera Therapeutics, Inc., CEO total pay: 8601747 · Pay ratio (CEO : median worker): 21:1Kymera Therapeutics, Inc.Nuvalent, Inc., CEO total pay: 540474 · Pay ratio (CEO : median worker): 21:1Nuvalent, Inc.
Arvinas, Inc. vs. Chemicals & Pharmaceuticals peers, plotted against the industry's $7.9M median CEO total and 42:1 median pay ratio.

Ratio bands among Chemicals & Pharmaceuticals peers

Exclusive CEO-to-median-worker bands across 153 complete latest-FY filings in SIC 28. Segments sum to the peer set, not this company's compensation pillar.

CEO Compensation Breakdown, FY2025

A component-level pay breakdown is not reported in Arvinas, Inc.'s structured SEC pay-ratio disclosure. See our methodology →

Filing-year trail · Arvinas, Inc.

Complete DEF 14A pay-ratio filings for this CIK across FY2021–2025. Year-over-year deltas compare adjacent filing years only; incomplete dollar rows are omitted (same completeness gate as the hero figures).

Latest ratio
20:1
FY2025
vs prior FY
-24:1
from FY2024 44:1
CEO $ YoY
+12%
$328K latest
Filings shown
5
FY2021–2025
Arvinas, Inc. CEO total compensation, median worker pay, and pay ratio by fiscal year from SEC EDGAR DEF 14A.
FY CEO pay Δ pay Median worker Pay ratio Δ ratio
2021 $289K - $288,956 44:1 -
2022 $284K -1.7% $284,130 34:1 -10:1
2023 $266K -6.3% $266,130 29:1 -5:1
2024 $293K +9.9% $292,571 44:1 +15:1
2025 $328K +12% $327,724 20:1 -24:1

Source: SEC EDGAR DEF 14A pay-ratio disclosures for CIK 1655759, FY2021–2025. Adjacent-year deltas only.

Industry Comparison - Chemicals & Pharmaceuticals

This Company's Ratio
20:1
Industry Median Ratio
42:1
Industry Median CEO Pay
$7.9M
This CEO's Pay
$328K
Companies in Industry
168
vs. Industry Median
Below
#127 of 168 by pay ratio in this industry View all companies in Chemicals & Pharmaceuticals →

Arvinas, Inc.: near-parity Item 402(u) ratio

Arvinas, Inc.'s FY2025 ratio 20:1 ranks #127 of 168 Chemicals & Pharmaceuticals filers (25th percentile). the CEO earned 20× the median employee ($327,724) in FY2025.

At $327,724 median worker pay, the FLOOR stamp is near pay-parity territory under MICRO CEO total.

CEO Total Pay

$328K

FY2025 Summary Compensation, below median

Pay Ratio

20:1

Below typical

Arvinas, Inc. in the lower Chemicals & Pharmaceuticals third

Arvinas, Inc.'s FY2025 ratio 20:1 ranks #127 of 168 Chemicals & Pharmaceuticals filers (25th percentile). The structured pay-ratio disclosure reports the total without line-item components. Chemicals & Pharmaceuticals (SIC 28) median ratio is 42:1 across 168 FY2025 filers; Arvinas, Inc.'s $328K CEO total is at or below the $7.9M industry median CEO pay.

Dollar rank #1303 and ratio rank #1215 split - treat 20:1 as a disclosure, not a fairness score. Open Chemicals & Pharmaceuticals peers.

Key Data, FY2025

Total Compensation
$328K
Median Employee Pay
$327,724
Pay Ratio
20:1
Filing Date
2026-04-29

Company Info

Ticker
ARVN
CIK
1655759
Industry
Chemicals & Pharmaceuticals
SIC Code
2834
State
DE
View SEC filings →
SEC EDGAR DEF 14A for CIK 1655759, FY2025. Informational only, not investment advice. Verify on EDGAR.

Read our methodology - how this data is sourced, computed, and verified. Arvinas, Inc.'s FY2025 ratio 20:1 ranks #127 of 168 Chemicals & Pharmaceuticals filers (25th percentile).

Read with Arvinas, Inc.

ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps FLOOR · MICRO · ELITE-MED.

Wintrust Financial Corp · MICRO

ABS(ceo_total_comp) peer at $326K (Δ $2K lighter vs Arvinas, Inc.); FLOOR · HIGH-MED vs this page's FLOOR · MICRO · ELITE-MED.
SunCoke Energy, Inc. · MICRO

ABS(ceo_total_comp) peer at $330K (Δ $2K heavier vs Arvinas, Inc.); FLOOR · HIGH-MED vs this page's FLOOR · MICRO · ELITE-MED.
Snowflake Inc. · MICRO

ABS(ceo_total_comp) peer at $331K (Δ $3K heavier vs Arvinas, Inc.); MODEST · ELITE-MED vs this page's FLOOR · MICRO · ELITE-MED.
Home Bancshares Inc · MICRO

ABS(ceo_total_comp) peer at $332K (Δ $4K heavier vs Arvinas, Inc.); FLOOR · PAR-MED vs this page's FLOOR · MICRO · ELITE-MED.
Syndax Pharmaceuticals Inc (SIC 28 pole)

Syndax Pharmaceuticals Inc stamps FLOOR · HEAVY nearest in-SIC by ABS(pay_ratio) to Arvinas, Inc.'s FLOOR filing.
National dual ranks · #1303/#1215

Arvinas, Inc.'s FY2025 package sits #1303 by CEO dollars and #1215 by ratio under MICRO · FLOOR.
Ratio primer · FLOOR

Arvinas, Inc.'s FLOOR stamp sits in the lower Item 402(u) band - start with how the ratio is disclosed before comparing peers.
Data sourced from SEC EDGAR DEF 14A for Arvinas, Inc. (CIK 1655759), FY2025. See our methodology. Aggregated by PlainCEOPay as of August 2026.

Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.